@EMA_News to review @MylanNews and @Bioconlimited #Regulatory #submissions for proposed #Biosimilars Trastuzumab https://t.co/0s4V0cAv9S
@EMA_News to review @MylanNews and @Bioconlimited #Regulatory #submissions for proposed #Biosimilars Trastuzumab https://t.co/0s4V0cAv9S